Pediatrix Medical Group (MD) Stock Forecast & Price Target
$2.36B
Market Cap
13.70
P/E
12.37
Forward P/E
57
Score
MD price $29.05 +0.14 +0.48%
Stocklytics score rationale: value 62, quality 60, growth 48.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 3183159000 | 3458312000 | 3647123000 | 1779759000 | 1733951000 | 1911191000 | 1972021000 | 1994640000 | 2012919000 | 1913849000 |
Pediatrix Medical Group, Inc. delivers specialized medical services for newborns, expectant mothers, and pediatric patients across the United States and Puerto Rico. The company offers crucial neonatal care to critically ill or prematurely born infants within hospital units, staffed by expert neonatal subspecialists and advanced practice clinicians. For pregnant individuals and their developing babies, Pediatrix…
Consensus Hold from 7 analysts. Average price target $26.60, -8.4% versus the current price. Low $24.00. High $28.00.
Insights · Dividends · Forecast · Financials · Learn
Analysts have an average 12-month price target of $26.60 for Pediatrix Medical Group (MD), 8.4% below the current price of $29.05. Of 7 analysts covering the stock, 1 rate it Buy or Strong Buy, 6 Hold, and 0 Sell or Strong Sell, giving a consensus of Hold.
Forecasts are third-party estimates and often wrong. They are not investment advice.
| Low | $24.00 |
|---|---|
| Average | $26.60 |
| High | $28.00 |
The average is 8.4% below the current price of $29.05.
Of 7 analysts, 1 rate Pediatrix Medical Group Buy or Strong Buy, 6 Hold, and 0 Sell or Strong Sell. The consensus label is Hold. That split is not a recommendation.
Analyst averages on file: 2026, EPS $2.35, revenue $1.96 billion. 2027, EPS $2.44, revenue $2.01 billion.
The Stocklytics Score for MD is 57 out of 100. It averages value, quality, and growth against a large-cap US universe. It is not a price target and not a buy or sell rating. Fair value is a separate estimate on the fair value tab.
$26.60 average, with a published range of $24.00 to $28.00.
The consensus is Hold from 7 analysts. This is not a recommendation.
Analysts' average EPS estimate for 2026 on file is $2.35. The average revenue estimate is $1.96 billion.
No reliable forecast exists that far out.
The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.
Related: Pediatrix Medical Group · Financials · Dividends · Compare · AI stocks
Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.
$2.36B
Market Cap
13.70
P/E
12.37
Forward P/E
57
Score